FCA Suits Over Poor Drug Quality Are Down But Not Out
The Fourth Circuit's new ruling that sloppy drugmaking can't support False Claims Act cases is the latest blow to lawsuits that equate regulatory noncompliance with fraud, but experts say whistleblowers and...To view the full article, register now.
Already a subscriber? Click here to view full article